期刊文献+

头孢尼西钠在儿科住院患儿的临床应用分析 被引量:1

Analysis of Clinical Application of Cefenime Sodium in Pediatric Inpatients
下载PDF
导出
摘要 目的对头孢尼西钠在儿科临床应用情况进行综合评价,为规范和指导儿童临床合理用药提供参考。方法回顾性分析某院儿科2016年1月至2017年12月入院并使用头孢尼西钠的住院患儿,记录并分析患儿的基本情况、用药信息和不良反应发生情况。结果共收集病例1 438份,87.69%的患儿处于婴幼儿期和学龄前。所有使用头孢尼西钠的患儿中,给药途径选择、溶媒种类选择使用情况较好,均为100%合理。86.09%符合用药目的;32.68%的患儿用药时间过长(>7 d);以体质量换算,大多数患儿用药剂量过大。结论该院儿科头孢尼西钠临床使用总体较为规范,使用相对安全。对于临床不合理用药问题,建议开展有效性和安全性评价,保障儿童用药安全。 Objective To assess clinical use of Cefonicid sodium in pediatric inpatients,in order to provide the basis for a normative and optimized medication.Methods Clinical data of Cefonicid sodium in pediatric inpatients in our hospital from January 2016 to December 2017 were recorded and analyzed,which included fundamental state,medical information and adverse reactions occurred.Results A total of 1438 inpatients were collected in the study.In practice,the main patients(accounted for 46.48%)are pre-school age.It was reasonable for routes of administration and choices of vehicle.Of all drug use,86.69%satisfied medication purpose,32.68%showed too long medication.In terms of body mass conversion,most of the children took too much medicine.Conclusion Clinical use is generally standardized of Cefonicid sodium in pediatrics department and relative safety.For the irrational use of drugs,evaluation of effectiveness and safety should be strengthened,it is necessary to ensure medication safety in children.
作者 张雷 ZHANG Lei(Traditional Chinese Medicine Hospital Pharmacy of Kunshan,Kunshan Jiangsu 215300,China)
出处 《中国药物警戒》 2020年第10期720-723,共4页 Chinese Journal of Pharmacovigilance
关键词 头孢尼西钠 回顾性分析 用药评价 儿科 cefonicid sodium retrospective analysis evaluation of drug use pediatric
  • 相关文献

参考文献10

二级参考文献100

  • 1孟庆明,曹风梅.试论β内酰胺类与大环内酯类抗生素联合应用的合理性[J].中华结核和呼吸杂志,2003,26(11):721-721. 被引量:65
  • 2楼洪刚,刘芳,翟所迪.氨溴索雾化吸入治疗肺炎的系统评价[J].中国循证医学杂志,2006,6(6):421-429. 被引量:41
  • 3胡敏,胡昌勤.LC-MS法分析头孢硫脒降解产物[J].药学学报,2006,41(10):1015-1019. 被引量:27
  • 4Michael E. Oral ceftibuten as step-down therapy after parenteral 3rd generation cephalospofin treatment for serious infection [ J ]. Can J Infect Dis, 1995,6: 355.
  • 5顾苏俊,单文治,陈宜鸿.进行医院药事风险管理的探讨[J].医药导报,2007,26(7):824-826. 被引量:8
  • 6Thakur AK, Chatterjee SS, Kumar V. Adaptogenic potential of andrographolide: An active principle of the king of bitters (Andrographis paniculata)[J]. J Tradit Complement Med, 2015,5(1) :42-50.
  • 7Preet R, Chakraborty B, Siddharth S, etal. Synthesis and bi- ological evaluation of andrographolide analogues as anti-cancer agents[J]. Eur J Med Chem,2014,85:95-106.
  • 8Wen L, Xia N, Chen X, et al. Activity of antibacterial, anti- viral, anti-inflammatory in compounds andrographolide salt [J]. Eur J Pharmacol,2014,740=421-427.
  • 9北京爱琴海乐之技术有限公司.NoteExpress参考文献管理与检索系统[DB/CD].3.0.北京:2005.
  • 10国家食品药品监督管理总局.国家食品药品监督管理总局发布2014年药品不良反应监测年度报告[EB/OL].[2015-07-17].http//www.sda.gov.cn.

共引文献107

同被引文献19

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部